Kestra Medical Technologies KMTS

Kestra Medical Technologies, Ltd. · Nasdaq · Surgical & Medical Instruments & Apparatus

$29.87-0.40%close on Oct. 28, 2026 · volume 538K · Yahoo Finance

Price, last 47 sessions

$24.00$26.00$28.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $29.99 · low $22.85 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 21, 2026Traci S. Umberger
See Remarks, director
Sold
10b5-1 plan
100,000$27.18
$27.15-$28.09
$2.72 million
Oct. 20, 2026Brian Daniel Webster
See Remarks, director
Sold
10b5-1 plan
15,000$29.56
$29.52-$29.89
$443,389
Sept. 30, 2026Raymond W. Cohen
director
Sold3,330$29.28$97,504
Sept. 21, 2026Elizabeth Kwo
director
Sold4,010$24.26$97,268
Sept. 8, 2026Jeffrey Lawrence Schwartz
director, 10% owner
Sold3,890$25.18$97,942
Sept. 8, 2026Conor Hanley
director
Sold5,694$25.25$143,779
Sept. 8, 2026Kevin C. Reilly
director
Sold2,932$25.13$73,677
Sept. 8, 2026Mary Kay Ladone
director
Sold3,908$25.20$98,464
Aug. 17, 2026Brian Daniel Webster
See Remarks, director
Sold
10b5-1 plan
15,000$27.48$412,180
Aug. 7, 2026Vaseem Mahboob
Chief Financial Officer
Sold
10b5-1 plan
26,287$25.88
$25.87-$26.33
$680,383
Aug. 4, 2026Alfred J. Ford Jr
Chief Commercial Officer
Sold6,275$24.09$151,141
Aug. 4, 2026Vaseem Mahboob
Chief Financial Officer
Sold
10b5-1 plan
6,995$24.68
$24.06-$25.17
$172,635

Latest 12 of 29. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 25 →